FDA Clearance Tracker · P150004-S020
Proclaim Dorsal Root Ganglion (DRG) External Programmer Apps
Last checked: Nov 20, 2026Latest source record: Jul 19, 2018 (this decision)Source: openFDAMethods & limitations
Decided
Jul 19, 2018
Approved
Time to decision
156 days
Received Feb 13, 2018. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P150004-S020
- Device name
- Proclaim Dorsal Root Ganglion (DRG) External Programmer Apps
- Applicant
- ABBOTT MEDICAL
- Applicant location
- Plano, TX
- Received
- Feb 13, 2018
- Decided
- Jul 19, 2018
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P150004
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval for:1) P140009/S037: MR Conditional labeling, Firmware version 1.3, and Clinician Programmer and Patient Controller Apps version 3.7 (DBS MRI mode, DBS shared frequency mode, DBS Multistim Programming, DBS Monopolar Survey Mode, and minor software changes); and2) P010032/S141 and P150004/S20: Firmware version 1.3 and Clinician Programmer and Patient Controller Apps version 3.7 (minor software changes).
Source documents
Other decisions for ABBOTT MEDICAL
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P260019 · Decided Oct 27, 2026 · 180 days after receipt
Device type: Para-device leak occluder (SJT) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.